Sofinnova Investments, Inc. Prometheus Biosciences, Inc. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$103.46 - $126.29 $5.45 Million - $6.66 Million	-52,703 Reduced 29.85%	123,842 $13.3 Million
Q4 2022 Feb 13, 2023	BUY	$36.06 - $117.21 $1.33 Million - $4.31 Million	36,771 Added 26.31%	176,545 $19.4 Million
Q3 2022 Nov 08, 2022	SELL	$28.17 - $59.01 $6.95 Million - $14.6 Million	-246,621 Reduced 63.83%	139,774 $8.25 Million
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $8.65 Million - $15 Million	386,395 New	386,395 $10.9 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.